Antisera to selected outer membrane proteins of Vibrio cholerae protect against challenge with homologous and heterologous strains of V. cholerae

FEMS Immunology and Medical Microbiology

Volumn 22, Issue 4, 1998, Pages 303-308

  Das, Margaret ^a   Chopra, Ashok K ^a   Cantu, Juan M ^a   Peterson, Johnny W ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cholera vaccine; Immunogenic surface protein; Vibrio cholerae

Indexed keywords

ANTISERUM; CHOLERA VACCINE; OUTER MEMBRANE PROTEIN;

ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIBRIO CHOLERAE;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CHOLERA; ESCHERICHIA COLI PROTEINS; FEMALE; MOLECULAR SEQUENCE DATA; RABBITS; VIBRIO CHOLERAE;

EID: 0032405753     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00101-1     Document Type: Article

References (18)

1. World Health Organization (1997) Conquering Suffering, Enriching Humanity. World Health Organization, Geneva.
2. Levine, M.M., Black, R.E., Clements, M.L., Cisneros, L., Nalin, D.R. and Young, C.R. (1981) Duration of infection-derived immunity to cholera. J. Infect. Dis. 143, 818-820.
3. Levine, M.M. and Pierce, N.F. (1992) Immunity and vaccine development. In: Cholera (Greenough, W.B. III and Barua, D., Eds.), pp. 285-327. Plenum Press, New York.
4. Levine, M.M., Kaper, J.B., Herrington, D., Ketley, J., Losonsky, G., Tacket, C.O., Tall, B. and Cryz, S. (1988) Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet ii, 467-470.
5. Michalski, J., Galen, J.E., Fasano, A. and Kaper, J.B. (1993) CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect. Immun. 61, 4462-4468.
6. Simanjuntak, C., O'Hanley, P., Punjabi, N.H., Noriega, F., Pazzagalia, G., Dykstra, P., Kay, B., Suharyono, Budiaro, A., Rifai, A.R., Wasserman, S.S., Losonsky, G., Kaper, J., Cryz, S. and Levine, M.M. (1993) Safety, immunogenicity, and transmissibility of single-dose live oral cholerae vaccine strain CVD 103-HgR in 24-59-month-old Indonesian children. J. Infect. Dis. 168, 1169-1176.
7. Tacket, C.O., Losonsky, G., Nataro, J.P., Cryz, S.J., Edelman, R., Fasano, A., Michalski, J., Kaper, J.B. and Levine, M.M. (1993) Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a ΔctxA Δzot Δace derivative of El Tor Ogawa Vibrio cholerae. J. Infect. Dis. 168, 1536-1540.
8. Albert, M.J., Alam, K., Ansaruzzaman, M., Qadri, F. and Sack, R.B. (1994) Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae vaccine strain CVD103-HgR. J. Infect. Dis. 169, 230-231.
9. De, S.N. (1959) Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature 183, 1533-1534.
10. Verwey, W.F., Watanabe, Y., Philips, P.E. and Williams, H.R. Jr. (1965) In: Proceedings of the Cholera Research Symposium (Bushnell, O.A. and Brookhyser, C.S., Eds.), pp. 259-263.
11. Filip, C., Fletcher, G., Wulff, J.L. and Earhart, C.F. (1973) Solubilization of the cytoplasmic membrane of E. coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol. 115, 717-722.
12. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Jalajakumari, M.B. and Manning, P.A. (1990) Nucleotide sequence of the gene, OmpW encoding a 22 kDa immunogenic outer membrane protein of Vibrio cholerae. Nucleic Acids Res. 18, 2180.
14. Sperandio, V., Bailey, C., Giron, J.A., DiRita, V.J., Silveira, W.D., Vettore, A.L. and Kaper, J.B. (1996) Cloning and characterization of the gene encoding the OmpU outer membrane protein of Vibrio cholerae. Infect. Immun. 64, 5406-5409.
15. Chakrabarti, S.R., Chaudhuri, K., Sen, K. and Das, J. (1996) Porins of Vibrio cholerae: purification and characterization of OMPU. J. Bacteriol. 178, 524-530.
16. Attridge, S.R. and Rowley, D. (1983) Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. J. Infect. Dis. 148, 931-939.
17. Weintraub, A., Widmalm, G., Jansson, P.-E., Jansson, M., Hultenby, K. and Albert, M.J. (1994) Vibrio cholerae O139 bengal possesses a capsular polysaccharide which may confer increased virulence. Microb. Pathogen. 16, 235-241.
18. Calia, K.E., Murtagh, M., Ferraro, M.J. and Calderwood, S.B. (1994) Comparison of Vibrio cholerae O139 with V. cholerae O1 Classical and El Tor biotypes. Infect. Immun. 62, 1504-1506.